Lv5
960 积分 2023-09-09 加入
Two phase 3 study results of children and adults with mild-to-moderate atopic dermatitis treated with Crisaborole Topical Ointment, 2%, a novel, nonsteroidal, topical, anti-inflammatory, phosphodiesterase 4 inhibitor
4天前
求助中
Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: results of a randomized, vehicle-controlled, multicenter clinical trial
4天前
已完结
A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis
4天前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
20天前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
20天前
已完结
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
20天前
已完结
Future Possibility of Mizagliflozin on Functional Constipation and/or Irritable Bowel Syndrome with Constipation
21天前
已完结
Inhibiting glucose absorption to treat constipation
21天前
已完结
Mizagliflozin for the Treatment of Functional Constipation: Are New Drugs Better?
21天前
已完结
SGLT1 as an adverse prognostic factor in invasive ductal carcinoma of the breast
21天前
已完结
皖公网安备34019202002308
